Patents by Inventor Stephane Schurmans

Stephane Schurmans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule
    Patent number: 7094546
    Abstract: The present invention is related to an inhibitor of the inositol polyphosphate 5-phosphatase SHIP2 protein or its encoding nucleotide sequence identified by SEQ ID NO. 1 or of SHIP2 mRNA expression. The present invention is also related to a pharmaceutical composition comprising said inhibitor and an adequate pharmaceutically acceptable carrier or diluent and to a non-human knock-out mammal comprising homozygously or heterozygously a partial or total deletion in its genome of the inositol polyphoshate 5-phosphatase SHIP2 nucleotide sequence.
    Type: Grant
    Filed: December 19, 2003
    Date of Patent: August 22, 2006
    Assignee: Euroscreen, S.A.
    Inventors: Christopher Erneux, Stephane Schurmans
  • Inhibitors of the inositol polyphosphate 5-phosphate SHIP2 molecule
    Patent number: 6936452
    Abstract: The present invention is related to an inhibitor of the inositol polyphosphate 5-phosphatase SHIP2 protein or its encoding nucleotide sequence identified by SEQ ID NO. 1 or of SHIP2 mRNA expression. The present invention is also related to a pharmaceutical composition comprising said inhibitor and an adequate pharmaceutically acceptable carrier or diluent and to a non-human knock-out mammal comprising homozygously or heterozygously a partial or total deletion in its genome of the inositol polyphoshate 5-phosphatase SHIP2 nucleotide sequence.
    Type: Grant
    Filed: December 19, 2003
    Date of Patent: August 30, 2005
    Assignee: Euroscreen s.a.
    Inventors: Christopher Erneux, Stephane Schurmans
  • Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule
    Publication number: 20050183146
    Abstract: The present invention is related to an inhibitor of the inositol polyphosphate 5-phosphatase SHIP2 protein or its encoding nucleotide sequence identified by SEQ ID NO. 1 or of SHIP2 mRNA expression. The present invention is also related to a pharmaceutical composition comprising said inhibitor and an adequate pharmaceutically acceptable carrier or diluent and to a non-human knock-out mammal comprising homozygously or heterozygously a partial or total deletion in its genome of the inositol polyphoshate 5-phosphatase SHIP2 nucleotide sequence.
    Type: Application
    Filed: December 19, 2003
    Publication date: August 18, 2005
    Inventors: Christopher Erneux, Stephane Schurmans
  • Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule
    Publication number: 20040209342
    Abstract: The present invention is related to an inhibitor of the inositol polyphosphate 5-phosphatase SHIP2 protein or its encoding nucleotide sequence identified by SEQ ID NO. 1 or of SHIP2 mRNA expression.
    Type: Application
    Filed: December 19, 2003
    Publication date: October 21, 2004
    Applicant: Euroscreen, s.a.
    Inventors: Christopher Erneux, Stephane Schurmans
  • Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule
    Publication number: 20040203087
    Abstract: The present invention is related to an inhibitor of the inositol polyphosphate 5-phosphatase SHIP2 protein or its encoding nucleotide sequence identified by SEQ ID NO. 1 or of SHIP2 mRNA expression.
    Type: Application
    Filed: December 19, 2003
    Publication date: October 14, 2004
    Applicant: Euroscreen, s.a.
    Inventors: Christopher Erneux, Stephane Schurmans
  • Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule
    Patent number: 6703215
    Abstract: The present invention is related to an inhibitor of the inositol polyphosphate 5-phosphatase SHIP2 protein or its encoding nucleotide sequence identified by SEQ ID NO. 1 or of SHIP2 mRNA expression. The present invention is also related to a pharmaceutical composition comprising the inhibitor and an adequate pharmaceutically acceptable carrier or diluent and to a non-human knock-out mammal comprising homozygously or heterozygously a partial or total deletion in its genome of the inositol polyphoshate 5-phosphatase SHIP2 nucleotide sequence.
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: March 9, 2004
    Assignee: Euroscreen, s.a.
    Inventors: Christopher Erneux, Stephane Schurmans
  • Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule
    Publication number: 20020106713
    Abstract: The present invention is related to an inhibitor of the inositol polyphosphate 5-phosphatase SHIP2 protein or its encoding nucleotide sequence identified by SEQ ID NO. 1 or of SHIP2 mRNA expression.
    Type: Application
    Filed: August 3, 2001
    Publication date: August 8, 2002
    Inventors: Christopher Erneux, Stephane Schurmans